Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) Q1 2023 Earnings Call Transcript May 11, 2023
Cyclacel Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.47, expectations were $-0.66.
Operator: Good afternoon, and welcome to the Cyclacel Pharmaceuticals First Quarter 2023 Results Conference Call and Webcast. At this time, all participants are in a listen-only mode. After today’s call members of the financial community will have the opportunity to ask questions. [Operator...
